ONCOLYTIC IMMUNOTHERAPY
Dead / Abandoned — Abandoned — failure to respond (as of 23 Jan 2025)
What this means for you
This application is over — abandoned 08 Jan 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98452032
- Mark type
- Stylized text
- Filed
- 15 Mar 2024
- Abandoned
- 08 Jan 2025
- Attorney of record
- Perry J. Viscounty
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer; pharmaceutical preparations and biological preparations for the treatment of cancer and immunological disorders; Biopharmaceuticals for the treatment of cancer, namely, antibodies, non-antibody proteins, blood and blood components, stem cells, hormones, blood factors, tumor necrosis factors; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Providing medical and scientific research information in the fields of oncology, autoimmune disorders, immunotherapy, immunotherapeutics, biotechnology, biopharmaceuticals, pharmaceuticals, therapies, diseases, and disorders
Owner
- CG Oncology, Inc., Irvine, CA, US
Prosecution history
- 23 Jan 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 23 Jan 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 07 Oct 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 Oct 2024 — NON-FINAL ACTION E-MAILED
- 07 Oct 2024 — NON-FINAL ACTION WRITTEN
- 25 Sept 2024 — ASSIGNED TO EXAMINER
- 12 Sept 2024 — TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
- 12 Sept 2024 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 09 Aug 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Mar 2024 — NEW APPLICATION ENTERED